Rbf Capital, LLC Vista Gen Therapeutics, Inc. Transaction History

Rbf Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$0.65 - $1.94 $16,250 - $48,500	-25,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$0.48 - $1.03 $88,800 - $190,550	-185,000 Reduced 88.1%	25,000 $17,000
Q3 2020 Nov 16, 2020	BUY	$0.48 - $1.03 $88,800 - $190,550	185,000 Added 740.0%	210,000 $1.37 Million
Q2 2020 Aug 14, 2020	BUY	$0.37 - $0.61 $9,250 - $15,250	25,000 New	25,000 $13,000
Q1 2020 May 18, 2020	SELL	$0.32 - $0.8 $8,000 - $20,000	-25,000 Closed	0 $0

Q2 2018 Aug 14, 2018	BUY	$0.85 - $1.5 $21,250 - $37,500	25,000 New	25,000 $35,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.